読み込み中
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
通常取引
$22.88
−$0.60 · -2.56%
日中の時刻はETです。市場データは遅延する場合があります。
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
日中レンジ
現在 $22.88
52週レンジ
現在 $22.88
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
73
割安
センチメント
53
まちまち
リスク
45
やや高いリスク
モメンタム
52
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
日中レンジ
現在 $22.88
52週レンジ
現在 $22.88
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 |
|---|---|---|---|---|
| 売上高 | 8906.3万 USD | 6544.4万 USD | 4522.5万 USD | 2592.2万 USD |
| 売上原価 | 1078.9万 USD | 869.4万 USD | 706.2万 USD | 443万 USD |
| 粗利益 | 7827.4万 USD | 5675万 USD | 3816.3万 USD | 2149.2万 USD |
| 研究開発 | 1914.3万 USD | 1356.2万 USD | 899.5万 USD | 724.3万 USD |
| 販売・一般管理 | 1.18億 USD | 8289.7万 USD | 5920.9万 USD | 5027万 USD |
| 営業費用 | 1.37億 USD | 9645.9万 USD | 6820.4万 USD | 5751.3万 USD |
| 支払利息 | 189万 USD | 199.2万 USD | 209.8万 USD | 160.3万 USD |
| 減価償却費と償却費 | 134.1万 USD | 114.1万 USD | 84.7万 USD | 49.7万 USD |
| 営業利益 | −5840.2万 USD | −3970.9万 USD | −3004.1万 USD | −3602.1万 USD |
| 純利益 | −5341.2万 USD | −4045.5万 USD | −2946.4万 USD | −3716.4万 USD |
会社概要が更新されました 2026年10月8日.
直近の発表実績
直近の発表実績
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI2039.36万0.00%2.3兆 USD0.03%$379.43-0.42%
iShares Russell 2000 ETFIWM1710.44万0.02%785.63億 USD0.19%$274.85-1.03%
Vanguard Extended Market ETFVXF601.01万0.01%954億 USD0.05%$231.27-0.95%
iShares Russell 2000 Growth ETFIWO599.25万0.04%142.49億 USD0.24%$350.38-1.41%
Vanguard Russell 2000 ETFVTWO379.44万0.02%180億 USD0.06%$110.99-1.09%
Schwab U.S. Small-Cap ETFSCHA317.08万0.01%216.99億 USD0.03%$32.3099-0.92%
iShares U.S. Medical Devices ETFIHI295.36万0.08%35.04億 USD0.37%$50.5685-0.75%
F/M Emerald Life Sciences Innovation ETFLFSC220.17万1.86%1.16億 USD0.79%$40.925-2.19%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAiShares U.S. Medical Devices ETFIHIF/M Emerald Life Sciences Innovation ETFLFSCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
